GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

EyeGate Pharmaceuticals EYEG · USD

Health Care · US listing · 🇺🇸 United States

Compare

33.98

+0.12%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on EyeGate Pharmaceuticals

Our reporting

We have not reported on EyeGate Pharmaceuticals yet.

Past results

Reported against what analysts expected

8 May 20268 Nov 20249 Aug 202412 Aug 202112 May 202125 Mar 2021
Earnings per share-0.58-0.81-0.53-0.35-0.37-0.52
Forecast———-0.42-0.39-0.45
Revenue——$20,000——$12,000

Key events

  1. 30 Aug 201915-to-1 reverse split
  2. 13 Feb 2015Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.